These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32065286)

  • 1. Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
    Sodano C; Clauser P; Dietzel M; Kapetas P; Pinker K; Helbich TH; Gussew A; Baltzer PA
    Eur Radiol; 2020 Jun; 30(6):3371-3382. PubMed ID: 32065286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.
    Sun K; Chai W; Fu C; Zhan Y; Shen K; Luo X; Yan F
    Eur Radiol; 2016 Jun; 26(6):1565-74. PubMed ID: 26385807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the Kaiser score on clinical decision-making in BI-RADS 4 mammographic calcifications examined with breast MRI.
    Wengert GJ; Pipan F; Almohanna J; Bickel H; Polanec S; Kapetas P; Clauser P; Pinker K; Helbich TH; Baltzer PAT
    Eur Radiol; 2020 Mar; 30(3):1451-1459. PubMed ID: 31797077
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Montemezzi S; Cavedon C; Camera L; Meliadò G; Caumo F; Baglio I; Sardanelli F
    Radiol Med; 2017 Mar; 122(3):161-170. PubMed ID: 27981485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
    Suppiah S; Rahmat K; Mohd-Shah MN; Azlan CA; Tan LK; Aziz YF; Vijayananthan A; Wui AL; Yip CH
    Clin Radiol; 2013 Sep; 68(9):e502-10. PubMed ID: 23706826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of diffusion-weighted MRI: predicting axillary lymph node metastases in breast cancer.
    Chung J; Youk JH; Kim JA; Gweon HM; Kim EK; Ryu YH; Son EJ
    Acta Radiol; 2014 Oct; 55(8):909-16. PubMed ID: 24234236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of diffusion weighted imaging as supplement to dynamic contrast enhanced breast MRI: Can it help predict malignancy, histologic grade and recurrence?
    Roknsharifi S; Fishman MDC; Agarwal MD; Brook A; Kharbanda V; Dialani V
    Acad Radiol; 2019 Jul; 26(7):923-929. PubMed ID: 30293819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric breast MRI with 3T: Effectivity of combination of contrast enhanced MRI, DWI and 1H single voxel spectroscopy in differentiation of Breast tumors.
    Aribal E; Asadov R; Ramazan A; Ugurlu MÜ; Kaya H
    Eur J Radiol; 2016 May; 85(5):979-86. PubMed ID: 27130059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
    Cecil KM; Schnall MD; Siegelman ES; Lenkinski RE
    Breast Cancer Res Treat; 2001 Jul; 68(1):45-54. PubMed ID: 11678308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of breast ultrasound in mammography BI-RADS 0 and clinically indeterminate or suspicious of malignancy breast lesions.
    Dobrosavljević A; Rakić S; Nikoli B; Raznatović SJ; Dikić SD; Milosević Z; Jurisić A; Skrobić M
    Vojnosanit Pregl; 2016 Mar; 73(3):239-45. PubMed ID: 27295907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of diffusion weighted imaging and magnetic resonance spectroscopy in breast cancer patients with indeterminate dynamic contrast enhanced magnetic resonance imaging findings.
    Sharma U; Agarwal K; Hari S; Mathur SR; Seenu V; Parshad R; Jagannathan NR
    Magn Reson Imaging; 2019 Sep; 61():66-72. PubMed ID: 31128225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
    Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
    Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1H-MRS evaluation of breast lesions by using total choline signal-to-noise ratio as an indicator of malignancy: a meta-analysis.
    Wang X; Wang XJ; Song HS; Chen LH
    Med Oncol; 2015 May; 32(5):160. PubMed ID: 25895597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-field MR spectroscopy in the multiparametric MRI evaluation of breast lesions.
    Cavedon C; Meliadò G; Rossi L; Camera L; Baglio I; Caumo F; Montemezzi S
    Phys Med; 2016 Dec; 32(12):1707-1711. PubMed ID: 27637861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited value of multiparametric MRI with dynamic contrast-enhanced and diffusion-weighted imaging in non-mass enhancing breast tumors.
    Marino MA; Avendano D; Sevilimedu V; Thakur S; Martinez D; Lo Gullo R; Horvat JV; Helbich TH; Baltzer PAT; Pinker K
    Eur J Radiol; 2022 Nov; 156():110523. PubMed ID: 36122521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffusion Kurtosis at 3.0T as an in vivo Imaging Marker for Breast Cancer Characterization: Correlation With Prognostic Factors.
    Huang Y; Lin Y; Hu W; Ma C; Lin W; Wang Z; Liang J; Ye W; Zhao J; Wu R
    J Magn Reson Imaging; 2019 Mar; 49(3):845-856. PubMed ID: 30260589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between breast MRI and contrast-enhanced spectral mammography.
    Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
    Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.
    Sardanelli F; Fausto A; Di Leo G; de Nijs R; Vorbuchner M; Podo F
    AJR Am J Roentgenol; 2009 Jun; 192(6):1608-17. PubMed ID: 19457825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.